Juicy Marbles, known for its plant-based whole cuts, has released its cheapest meat analogue yet: a high-protein, high-fibre ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

But one Cleveland Clinic expert is imploring executives not to look away. "Preventive measures are often neglected because they don't generate revenue, but they are incredibly important," Leslie Cho, ...

DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...

Don't want to spend a fortune and break the bank on investing in growth stocks? If you're looking for cheap growth stocks to ...

The recipe to most happy investing outcomes is painfully simple. But if it were that easy, wouldn't everybody do it?

Many Americans have flocked to cheaper, compounded versions of GLP-1 weight loss drugs in lieu of brand-name treatments. That competition is cutting into demand for Novo Nordisk’s prescriptions, a ...

We recently compiled a list of the Jim Cramer Shed Light on These 8 Stocks Recently. In this article, we are going to take a ...

The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from legally selling cheap knockoff versions.

The 63-year-old CEO of Life Time Fitness says people always want to know his workout and supplement prescription. Here's how ...

While Novo Nordisk's ( NOVO-B.CO) full-year results were strong, the company did point to slightly softer sales in 2025, saying it expected them to grow between 16% and 24% this year.